1-9 of 9
Satyin Kaura
Close
Sort by
Journal Articles

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)

Steven R Arikian, Gary Binder, Craig Gibson, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, Frank A. Corvino, Jianyi Lee, Andy Surinach, Satyin Kaura, Saad Usmani
Journal: Blood
Blood (2015) 126 (23): 3294.
https://doi.org/10.1182/blood.V126.23.3294.3294
Published: 2015
Journal Articles

Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study

Thomas W. LeBlanc, MD MA, Cristina J Gasparetto, MD, Sascha A Tuchman, MD, Peter Sheldon, B.A., Alexandra Howson, PhD, Zeba M. Khan, PhD, Satyin Kaura, MSci, MBA, Amy P Abernethy, MD PhD
Journal: Blood
Blood (2014) 124 (21): 6010.
https://doi.org/10.1182/blood.V124.21.6010.6010
Published: 2014
Journal Articles

The Value of Survival Gains in Myelodysplastic Syndromes

Joanna MacEwan, PhD, Wes Yin, PhD, Zeba M. Khan, PhD, Satyin Kaura, MSci, MBA
Journal: Blood
Blood (2014) 124 (21): 2608.
https://doi.org/10.1182/blood.V124.21.2608.2608
Published: 2014
Journal Articles

Impact of Novel Treatments on Multiple Myeloma Survival

David Robinson, Satyin Kaura, MSci, MBA, Daniel Kiely, Mohamad A. Hussein, MD, Knar Nersesyan, Brian G. M. Durie, MD
Journal: Blood
Blood (2014) 124 (21): 5676.
https://doi.org/10.1182/blood.V124.21.5676.5676
Published: 2014
Journal Articles

The Budget Impact of Orphan Drugs in the U.S.: A 2007-2013 MIDAS Sales Data Analysis

Victoria Divino, Mitch Dekoven, MHSA, Weiying Wang, MPH, Michael Kleinrock, MA, R. Donald Harvey, PharmD, Rolin L Wade, RPh, MS, Satyin Kaura, MSci, MBA
Journal: Blood
Blood (2014) 124 (21): 736.
https://doi.org/10.1182/blood.V124.21.736.736
Published: 2014
Journal Articles

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Henry J Henk, PhD, Satyin Kaura, MEng, MBA, Zeba M. Khan, PhD, April Teitelbaum
Journal: Blood
Blood (2012) 120 (21): 4688.
https://doi.org/10.1182/blood.V120.21.4688.4688
Published: 2012
Journal Articles

Cost-Effectiveness of Zoledronic Acid Versus Clodronate In Patients with Multiple Myeloma From a Canadian Healthcare System Perspective.

Thomas E. Delea, M.S.I.A., Khalid El Ougari, PhD, Jason Rotter, BA, Alice Wang, MA, Satyin Kaura, MEng, MBA, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3812.
https://doi.org/10.1182/blood.V116.21.3812.3812
Published: 2010
Journal Articles

Retrospective Database Analysis of the Effect of Zoledronic Acid (ZOL) On Skeletal-Related Events (SREs) in Patients (Patients) with Multiple Myeloma (MM).

Henry J Henk, PhD, Satyin Kaura, Jose Ricardo Perez, Laura Becker
Journal: Blood
Blood (2009) 114 (22): 3881.
https://doi.org/10.1182/blood.V114.22.3881.3881
Published: 2009
Journal Articles

Retrospective Database Analysis of Patterns of Zoledronic Acid (ZOL) Treatment in Patients with Multiple Myeloma (MM) and Malignant Bone Lesions (BM).

Donna Spencer, Satyin Kaura, Jose Ricardo Perez, Henry J Henk, PhD
Journal: Blood
Blood (2009) 114 (22): 4944.
https://doi.org/10.1182/blood.V114.22.4944.4944
Published: 2009